4-Acetoxy-DET
| Systematic (IUPAC) name | |
|---|---|
| 3-(2-Diethylaminoethyl)-1H-indol-4-yl acetate | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| ATC code | ? |
| ChemSpider | 21106239 |
| Chemical data | |
| Formula | C16H22N2O2 |
| Mol. mass | 274.36 g/mol |
|
|
|
|
| |
|
4-Acetoxy-DET (4-Acetoxy-N,N-diethyltryptamine), also known as ethacetin, ethylacybin or 4-AcO-DET is a psychedelic tryptamine. It was first synthesized in 1958 by Albert Hofmann in the Sandoz lab.[1]
It is expected that the compound is quickly hydrolyzed into the free phenolic 4-HO-DET by serum esterases, but human studies concerning the metabolic fate of this drug are lacking.
Dosage [edit]
4-Acetoxy-DET is orally active, and dosages of 10–25 mg are common. Effects last 4–6 hours.[2] The free base is also active when smoked in a dose range of 5–20 mg.[1] Smoking 4-acetoxy-DET greatly speeds up the onset; peak effects are experienced within 10 minutes, and are usually over within 1 hour.[specify]
References [edit]
- ^ a b Erowid 4-Acetoxy-DET Vaults : Primer. Accessed on April 19, 2007.
- ^ Tikhal: The Chemistry Continues by Alexander and Ann Shulgin. #16. 4-HO-DET. Accessed on April 19, 2007.
External links [edit]
- Erowid 4-Acetoxy-DET vault
- (Swedish) Classification document by the Swedish Institute of Health regarding 4-Acetoxy-DET